Don't do it in medicine.

However, in real life, the implementation is not so smooth, due to a variety of subjective and objective factors, many drugs, especially some commonly used drugs, prices are still high.
To investigate its reasons, in fact, is very simple, the industry is very clear, is the drug layer control - control area, control prices, from the province, city, county every level have money to earn, invisible on the level of the price of drugs.
this is an open secret, most pharmaceutical companies are doing, of course, pharmaceutical companies have no way, you do not do others do, the big background is so, the end of the market is you.
the heart, in fact, which pharmaceutical companies are not willing to do, after all, the flowers are the real profits of enterprises.
Today, many pharmaceutical companies are using the marketing ideas of control, whether it is to do hospital clinical varieties, or in the chain pharmacy sales of OTC varieties, and then in the third terminal of the controlled varieties, are using different forms of control, price control, market control, control area.
each level has a certain operating space, each trader has a certain operating costs, prompting the entire sales chain in an orderly operation.
As a pharmaceutical company, to this end to increase the factory price and retail price of products, to ensure a steady rise in sales of their own products, otherwise it is difficult to stand in the market, because you do not do so, other manufacturers do, you will be the pharmaceutical market born out.
control prices, control areas control prices, control areas, in the prescribed areas, strict implementation of the control and marketing policies formulated by enterprises, to layer of costs to control from the factory - agents - distributors - end-customers at all levels of the price.
Never allow low-cost goods, not to allow low-cost goods to other regions, of course, now also does not allow the casual sale on the e-commerce platform, otherwise the light punishment of pharmaceutical company clerks, heavy termination of cooperation with agents.
A lot of pharmaceutical companies in the control of sales on this road very smoothly, not how good the products of these enterprises, but these enterprises of the control and marketing model works well, so that these enterprises have a rapid development opportunity.
These first to do the control mode and developed pharmaceutical enterprises, eventually became a lot of enterprises learning object or benchmark, thus driving more and more pharmaceutical companies have also done the control mode, so that the control and marketing has become the pharmaceutical market in recent years one of the most characteristic of the beautiful scenery.
A pharmaceutical enterprise originally did is the sale of circulation varieties, looking at those originally and their own similar variety structure of brother units, because a product added a packaging specifications, or again a trademark name, from the circulation of varieties into controlled sales varieties, open the price grade, from the circulation market to chain pharmacies, through the provincial total, total, county general level promotion, but a year or two actually made a gold single product, whether enterprises or individuals have earned a full pot.
not enviable, how can not let people follow the trend, who will not get through with the interests? Driven by interests, in this big background of infection, those who can still sink the air of the enterprise finally picked up the control of the sale of this panacea, to in-live business strategy.
open the interest chain of control and marketing, and then look at the provincial, land, county total three-level control and marketing model, which level is not all in the price of the article.
Thousands of ground troops, some counties have more than a dozen clerks, carpet-like covered with large and small pharmacies, all shapes and colors, one after another product promotion, such as in full swing, the wind and clouds like active in the pharmaceutical terminal this fertile land.
those who do not do control the sale of enterprises' products can not afford to lift their heads, and then good products, even if it is high-quality and low-cost products, can only become the bottom of the pressure box goods, always throw out, because no one, no cost to pull.
patients, health insurance to pay for the control of sales, nothing but on the basis of the original sales price has doubled five or six times, leaving room, set aside costs, for a level of promotion.
But the final bill is the patient, and now most pharmacies are hung up on the four big words of health insurance fixed point, and then the consumer groups are mostly able to swipe the card reimbursement, the final use of the national health insurance this part of the cost, that is, the government paid.
4 plus 7 with the volume of procurement is also good, low-cost winning bid, two-vote system, zero difference, the national level launched a wave after wave of health care reform policy, its purpose is to reduce drug prices, balance the cost of health care payment, so that patients can use high-quality and low-cost good medicine.
And the provincial total, the total, the county total three-level control mode, have done what, who is not stupid, an ordinary product, in the case of the same effect, just changed a face, the price went to the ground.
Now open all kinds of websites, there are still a large number of training advisory bodies are still constantly starting classes, teaching the provincial, local, county general three-level control mode, it is said that the business executives who came to participate in training there are many, all want to control the sale of this meal to a cup of their own.
the difficulty of controlling sales more and more high the origin and development of control sales, and that year's information is not flowing, consumers credious advertising, blindly listen to the promotion of shop assistants related.
with the intervention of e-commerce, price transparency is getting higher and higher, and consumers are spending more and more rationally, no longer blindly buying high-priced products promoted by shop assistants.
The difficulty of controlling sales is getting higher and higher, many well-known enterprises that have done more than ten years of control and sales also encountered the most difficult problems since the control of sales, the original price control is like iron barrels in general, and now is also always low-cost hanging on the e-commerce platform, even if the money to withdraw, is still more hanging, the lower the price.
From this point of view, the control of sales has gradually shown a weak side, one is not in line with the national level of price reduction policy;
this way, the control will go to the cross street, the next step how to go, is an unknown.
that is to say, once the door court if the city's control and marketing era is likely to change the Mencoro finch, once the grand gold signboard may also become a false proposition engraved in people's memory.
pharmaceutical companies do? What to do? Half a day to say there must always be a solution, there is an old saying: the solution is always more difficult.
from the national level, we will continue to expand the scope of the pilot cities and provinces of the "4 plus 7" and continue to increase the number of "4 plus 7" varieties, and significantly and extensively reduce the prices of high-end drugs.
from the enterprise side, the implementation of flat sales, reduce intermediate links, directly to end customers, the sale price of drugs down.
for example, a pharmaceutical company originally did is a second-level distribution system, layer by layer to control the price, but invisibly increased a level of costs, so-called price control are cost."
Now the enterprise adopts direct cooperation with dealers or agents with end-customers, because the manufacturer's supply price is unchanged, direct sales to dealers with a terminal network there, that dealers put the price of end-customers down, and so on, patients or consumers to buy the drug prices naturally fell a lot.
, the control of sales, price control, the intention is not good, but should be in the flat platform to run.
If the control of sales, price control is on the basis of layer-by-layer price increases, it is contrary to the original intention of the national health care policy, and ultimately will not be long-term, this is what I said control and marketing may become a false proposition of the true meaning.
.